These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1906527)

  • 1. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
    Brown EE; Damsma G; Cumming P; Fibiger HC
    J Neurochem; 1991 Aug; 57(2):701-7. PubMed ID: 1906527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.
    Westerink BH; Spaan SJ
    J Neurochem; 1982 Mar; 38(3):680-6. PubMed ID: 7057187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
    Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some factors affecting striatal 3-methoxytyramine concentrations in the mouse and rat.
    McQuade PS; Richard JW; Thakur M
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):725-9. PubMed ID: 4089199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
    Chai B; Meltzer HY
    Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral dialysis: direct evidence for the utility of 3-MT measurements as an index of dopamine release.
    Wood PL; Kim HS; Marien MR
    Life Sci; 1987 Jul; 41(1):1-5. PubMed ID: 3600173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.